Women who can’t take hormone therapy because of breast cancer or other diseases say they are deeply frustrated. By Liz Krieger Cybele Maylone, 46, has been hearing about hormone therapy nonstop.

# in a given time range. The search results will return metadata about available files. t_start_hrt = Time('2024-10-14T00:25:00', format='isot', scale='utc') t_end ...

Postmenopausal women struggling with weight loss may find a powerful solution by combining the diabetes drug tirzepatide with menopause hormone therapy. A Mayo Clinic study revealed that this dual ...

DMPA denotes depot medroxyprogesterone acetate, GAHT gender-affirming hormone therapy, GnRH gonadotropin-releasing hormone, HRT hormone-replacement therapy, and MPA medroxyprogesterone acetate.

Editor’s Note: This story has been updated with a new headline and additional information about the study’s limitations. Initiation of menopausal hormone therapy (HT) after age 65 was linked to ...

Hormone therapy is widely used to treat menopausal symptoms such as hot flushes and night sweats. But scientists have long debated whether it affects dementia risk. A new study adds another piece to ...

Estrogen patches, one of the most common forms of hormone therapy for women, are becoming harder to find, and some manufacturers say a recent action by Health and Human Services (HHS) Secretary Robert ...

For men who have a detectable PSA of 0.5 ng/mL or less after radical prostatectomy and before salvage radiation therapy, hormone therapy may provide no overall survival or metastasis-free survival ...

Pharmacies did not anticipate the surge of interest in this therapy for perimenopause and menopause symptoms, resulting in shortages. What should you do if you can’t get your patch? Estrogen patch ...

A nationwide shortage of estrogen patches used for hormone replacement therapy has prompted many women to look for alternatives for treating symptoms of menopause. Prescriptions for HRT have increased ...

Menopausal hormone therapy (commonly known as hormone replacement therapy or HRT) is not associated with an increased risk of death, finds a Danish study of over 800,000 women published in The BMJ.

The Food and Drug Administration approved the removal of certain warnings on labels for six menopausal hormone-replacement therapy (HRT) products. The new labeling doesn’t include risk statements ...